Repurposing Bromocriptine for Abeta Metabolism in Alzheimer's Disease

Clinical trial NCT04413344 · COMPLETED

Trial details

NCT number: NCT04413344
Sponsor: Kyoto University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Familial Alzheimer Disease (FAD)PSEN1 Mutation

Start date: 2020-06-05
Primary completion: 2021-11-24
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.